Valuation : Maravai LifeSciences Holdings, Inc.

Market Cap 1.14B 986M 924M 844M 1.59B 109B 1.59B 10.97B 4.28B 55.2B 4.3B 4.2B 183B P/E 2026 *
-25x
P/E 2027 * -32.3x
Enterprise Value 1.19B 1.03B 964M 880M 1.66B 114B 1.66B 11.44B 4.46B 57.56B 4.48B 4.38B 191B EV / Sales 2026 *
5.64x
EV / Sales 2027 * 5.07x
Free-Float
45.44%
Yield 2026 *
-
Yield 2027 * -
1 day-8.24%
1 week-11.11%
Current month+16.89%
1 month+16.54%
3 months+60.00%
6 months+115.73%
Current year+136.31%
1 week 7.64
Extreme 7.645
9.42
1 month 5.41
Extreme 5.41
9.42
Current year 2.8
Extreme 2.8
9.42
1 year 2.28
Extreme 2.285
9.42
3 years 1.66
Extreme 1.665
11.56
5 years 1.66
Extreme 1.665
61.59
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-07
Director of Finance/CFO 59 2025-06-29
Chief Operating Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 50 2016-02-29
Director/Board Member 65 2020-10-31
Director/Board Member 61 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
8/10/26 Tax

Chief Executive Officer

-29,250 0.0198%
7/30/26 Tax

Chief Financial Officer

-5,465 0.0037%
7/8/26 Tax

Chief Executive Officer

-29,250 0.0198%
Change 5-day change 1-year change 3-year change Capi.($)
-8.24%-11.11%+217.36%-26.30% 1.14B
-4.73%-3.08%+91.12%+277.10% 4.02B
-3.03%-3.38%+259.19%+30.88% 3.63B
-4.22%+2.43%+42.85%+64.79% 3.48B
-4.91%+2.43%+264.49%+442.37% 2.58B
-3.09%-6.35%-26.54%-26.21% 2.25B
+6.10%+7.10%+39.80% - 1.59B
+11.76%+16.89%+37.38%+60.22% 1.18B
-2.87%+25.09%+27.90%+184.74% 675M
+0.46%-0.56%-34.60%-2.07% 548M
Average -1.28%+0.07%+91.89%+111.72% 2.11B
Weighted average by Cap. -2.46%-0.49%+115.33%+138.22%

Financials

2026 *2027 *
Net sales 212M 182M 171M 156M 294M 20.22B 295M 2.03B 791M 10.21B 794M 777M 33.85B 226M 195M 182M 166M 314M 21.57B 315M 2.16B 844M 10.89B 848M 829M 36.11B
Net income -48.85M -42.1M -39.47M -36.03M -67.87M -4.67B -68.09M -468M -183M -2.36B -183M -179M -7.81B -33.6M -28.95M -27.14M -24.78M -46.68M -3.21B -46.83M -322M -126M -1.62B -126M -123M -5.37B
Net Debt 48.8M 42.05M 39.43M 35.99M 67.8M 4.66B 68.02M 468M 183M 2.35B 183M 179M 7.81B -385K -332K -311K -284K -535K -36.82M -537K -3.69M -1.44M -18.59M -1.45M -1.41M -61.63M
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
415
Date Price Change Volume
26-08-28 US$7.680 -8.24% 5,564,528
26-08-27 US$8.370 -5.96% 3,174,523
26-08-26 US$8.900 -1.11% 5,539,075
26-08-25 US$9.000 +6.76% 5,697,399
26-08-24 US$8.430 -2.43% 6,965,319
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
7.680USD
Average target price
7.300USD
Spread / Average Target
-4.95%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MRVI Stock